Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder Cancer By Ogkologos - November 4, 2024 1985 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SWOG S1011 study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Woman Showed Up To Their Wedding And Stole All Their Gifts.... March 11, 2019 Encouraging Early Results Seen with Novel MEDI1191 in Advanced Tumours March 1, 2021 Addressing Cancer Disparities and New Research in Treating HPV-Positive Head and... March 31, 2022 Online Dating During COVID-19 and Cancer: What to Know February 11, 2021 Load more HOT NEWS Patient Guide in Bladder Cancer Now Available Also in French Rise in Brain Metastases Detected in Patients with Stage IV NSCLC... GreaterGood Charities Provides Supplies and Support to People and Pets After... Sparing the Hippocampus During PCI Better Preserves Cognitive Function in Patients...
